New hope for advanced cancer: TJ101 trial begins
Disease control
Recruiting now
This early-phase trial tests TJ101, an experimental antibody-drug conjugate, in adults with advanced solid tumors (lung, prostate, esophageal, and others) who have no standard treatment options left. The main goals are to find a safe dose and see if the drug can shrink tumors. Ab…
Phase: PHASE1 • Sponsor: Phrontline Biopharma • Aim: Disease control
Last updated May 07, 2026 18:43 UTC